These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 25975751)
1. MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes. Choi JS; Nam MH; Yoon SY; Kang SH Leuk Res; 2015 Jul; 39(7):763-8. PubMed ID: 25975751 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression. Jang SJ; Choi IS; Park G; Moon DS; Choi JS; Nam MH; Yoon SY; Choi CH; Kang SH Leuk Res; 2016 Aug; 47():172-7. PubMed ID: 27379838 [TBL] [Abstract][Full Text] [Related]
3. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia. Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598 [TBL] [Abstract][Full Text] [Related]
4. Microarray analysis of differentially expressed microRNAs in myelodysplastic syndromes. Wan C; Wen J; Huang Y; Li H; Wu W; Xie Q; Liang X; Tang Z; Zhao W; Cheng P; Liu Z Medicine (Baltimore); 2020 Jul; 99(27):e20904. PubMed ID: 32629683 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix. Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y; World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598 [TBL] [Abstract][Full Text] [Related]
6. Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome. Wen J; Huang Y; Li H; Zhang X; Cheng P; Deng D; Peng Z; Luo J; Zhao W; Lai Y; Liu Z Int J Hematol; 2017 Jun; 105(6):777-783. PubMed ID: 28224273 [TBL] [Abstract][Full Text] [Related]
7. Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes. Vasilatou D; Papageorgiou SG; Kontsioti F; Kontos CK; Tsiotra P; Mpakou V; Pavlou MA; Economopoulou C; Dimitriadis G; Dervenoulas J; Pappa V Leuk Res; 2013 Mar; 37(3):251-8. PubMed ID: 23246221 [TBL] [Abstract][Full Text] [Related]
8. Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes. Wan C; Wen J; Liang X; Xie Q; Wu W; Wu M; Liu Z Sci Rep; 2021 Jan; 11(1):183. PubMed ID: 33420276 [TBL] [Abstract][Full Text] [Related]
9. Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes. Xu F; Zhu Y; He Q; Wu LY; Zhang Z; Shi WH; Liu L; Chang CK; Li X Sci Rep; 2016 Aug; 6():32232. PubMed ID: 27571714 [TBL] [Abstract][Full Text] [Related]
10. Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome. Hrustincova A; Krejcik Z; Kundrat D; Szikszai K; Belickova M; Pecherkova P; Klema J; Vesela J; Hruba M; Cermak J; Hrdinova T; Krijt M; Valka J; Jonasova A; Merkerova MD Cells; 2020 Mar; 9(4):. PubMed ID: 32224889 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of microRNA-597 in myelodysplastic syndromes induces apoptosis through FOSL2 inhibition. Kang SH; Kim HB; Choi JS Eur J Haematol; 2022 Dec; 109(6):680-685. PubMed ID: 36018564 [TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome. Choi Y; Hur EH; Moon JH; Goo BK; Choi DR; Lee JH Korean J Intern Med; 2019 Mar; 34(2):390-400. PubMed ID: 29132200 [TBL] [Abstract][Full Text] [Related]
14. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774 [TBL] [Abstract][Full Text] [Related]
15. Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables. Paydas S; Acikalin A; Ergin M; Celik H; Yavuz B; Tanriverdi K Med Oncol; 2016 Apr; 33(4):34. PubMed ID: 26951445 [TBL] [Abstract][Full Text] [Related]
16. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. Wang B; Li J; Sun M; Sun L; Zhang X IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313 [TBL] [Abstract][Full Text] [Related]
17. MiR-181a-2-3p as a potential diagnostic and prognostic marker for myelodysplastic syndrome. Liang X; Shi Z; Huang X; Wan C; Zhu S; Wu M; Li Z; Tang Z; Li J; Zhao W; Luo J; Liu Z Hematology; 2022 Dec; 27(1):1246-1252. PubMed ID: 36444993 [TBL] [Abstract][Full Text] [Related]
19. Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA). Koh Y; Lee HR; Song EY; Kim HK; Kim I; Park S; Park MH; Kim BK; Yoon SS; Lee DS Leuk Res; 2010 Oct; 34(10):1344-50. PubMed ID: 20427085 [TBL] [Abstract][Full Text] [Related]
20. Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome. Hussein K; Theophile K; Büsche G; Schlegelberger B; Göhring G; Kreipe H; Bock O Leuk Res; 2010 Mar; 34(3):328-34. PubMed ID: 19615744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]